✦ LIBER ✦

A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms

✍ Scribed by Alessandro Rambaldi; Chiara Maria Dellacasa; Guido Finazzi; Alessandra Carobbio; Maria Luisa Ferrari; Paola Guglielmelli; Elisabetta Gattoni; Silvia Salmoiraghi; Maria Chiara Finazzi; Silvia Di Tollo; Carmine D’Urzo; Alessandro M. Vannucchi; Giovanni Barosi; Tiziano Barbui

Book ID: 108676857
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 177 KB
Volume: 150
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08266.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic lymphocytic leukemia developing

Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm

✍ Ahmet Emre Eskazan; Ayse Salihoglu; Reyhan Diz-Kucukkaya; Veysel Sabri Hancer; T 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 55 KB

Prevalence of the JAK2-V617F mutation in

Prevalence of the JAK2-V617F mutation in Taiwanese patients with chronic myeloproliferative disorders

✍ C.-H. Lieu; H.-S. Wu; Y.-C. Hon; W.-H. Tsai; C.-F. Yang; C.-C. Wang; Y.-C. Lin; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Prevalence of the JAK2 V617F mutation in

Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms

✍ Tommaso Za; Alessia Fiorini; Elena Rossi; Angela Ciminello; Patrizia Chiusolo; G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Simultaneous occurrence of the JAK2V617F

Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders

✍ Yeo-Kyeoung Kim; Myung-Geun Shin; Hye-Ran Kim; Deok-Hwan Yang; Sang-Hee Cho; Je- 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 284 KB

The JAK2 V617F mutation involves B- and

The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders

✍ Thomas Stauffer Larsen; Jacob Haaber Christensen; Hans Carl Hasselbalch; Niels P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

Phase II study of the histone deacetylas

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

✍ Kristie A. Blum; Anjani Advani; Louis Fernandez; Richard Van Der Jagt; Joseph Br 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB